Bal Pharma (BOM:524824) Margin of Safety % (DCF Earnings Based): N/A (As of Jul. 05, 2026)


BOM:524824 Bal Pharma Ltd BOM:524824
65 GF Score
Price ₹78.12
GF Value ₹97.35
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Bal Pharma Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Bal Pharma's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

BOM:524824 vs ZTS, UTHR: Margin of Safety % (DCF Earnings Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Bal Pharma's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bal Pharma Margin of Safety % (DCF Earnings Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bal Pharma's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Bal Pharma's Margin of Safety % (DCF Earnings Based) falls into.


BOM:524824
65GF Score
Bal Pharma Ltd BOM:524824
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bal Pharma (BOM:524824) Overvalued in 2026?

Based on GuruFocus' analysis, Bal Pharma stock appears to be undervalued. The current stock price of ₹78.12 is trading 19.8% below its estimated GF Value™ of ₹97.35. GuruFocus considers Bal Pharma to be Modestly Undervalued.

Key valuation signals for BOM:524824:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: ₹97.35 vs. price of ₹78.12 (19.8% below fair value)
  • GF Score™: 65/100 with 5 warning signs

No single metric tells the full story. See the BOM:524824 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bal Pharma Business Description

Other Exchanges BALPHARMA:India
Address 10/1, Palace Road, 5th Floor, Lakshmi Narayan Complex, Bengaluru, KA, IND, 560052
Bal Pharma Ltd is a pharmaceutical company. It is principally engaged in the manufacturing and marketing of pharmaceutical formulations and active pharmaceutical ingredients. The company specializes in prescription drugs, generic and over-the-counter products, intravenous infusion, and bulk actives.
65GF Score

Get the complete analysis for BOM:524824

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹78.12
Price
₹97.35
GF Value